MRPS30-DT and lung carcinoma: There is a novel lncRNA BRCAT54 that is overexpressed in the lung cancer tissue, but this lncRNA benefits the patients, and its knockdown could promote the migration, proliferation, and apoptosis inhibition of lung cancer cells, which concern the regulation of JAK-STAT and calcium-related signaling pathways (53).